TOKYO, JAPAN / ACCESSWIRE / November 15, 2024 / Express Rx, recently announced the completion of a clinical study started in 2022, on its novel anti-aging complex, Cellumiva™, being the one of the first to apply the potent senolytic flavonoid,Procyanidin C1(PCC) to human trial.
The study, conducted over 12 weeks with a cohort of 72 participants aged 45-65, employed SA-β-gal staining to quantify senescent cell clearance and a skin-specific methylome model to analyze the biological age of skin. Additionally, clinical evaluations using standardized wrinkle scales and high-resolution skin imaging confirmed significant reductions in fine lines and wrinkles.
Cellumiva™, a combination of naturally-derived bioactive compounds, targets and clears senescent cells-often referred to as "zombie cells"-which accumulate with age and contribute to accelerated skin aging and dysfunction. By eliminating these cells, Cellumiva™ promotes the regeneration of healthy cells in skin, improving dermal structure, elasticity, and hydration. The outcomes emphasize the broad-spectrum anti-aging benefits of Cellumiva™, setting a new benchmark for nutraceutical skin health interventions.
For more information, visit ClinicalTrials.gov (Study ID: NCT06641869).
About Express Rx
Express Rx, head-quartered in Wyoming, united states, is a research-based pharmaceutical company and a pioneer in nutraceutical innovation. Express Rx is committed to applying cutting-edge scientific and technological advancements to the fields of aging, cellular health, metabolism, microbiome, and epigenetics. Through its premium nutraceutical brand, Paremina, Express Rx delivers clinically proven, high-quality products designed to enhance healthspan, combat the signs of aging, and support overall wellness.
About PAREMINA
PAREMINA, with origins in Switzerland, the brand offers specialized nutraceutical products with a focus in anti-aging solutions. With over 60 years of research in natural antioxidants and bioactives, Paremina's latest series of products, ‘BeautySpan' targets aging at a molecular level, developed on the belief that lasting beauty is a natural, biological indicator of lifelong well-being and radiance. For more information, please visit www.paremina.com.
About Cellumiva
Cellumiva™ is a cutting-edge senolytic complex that combines Procyanidin C1, Pterostilbene, and Spermidine to effectively reduce senescent cells in the skin, reversing biological skin aging. Procyanidin C1, as a novel senolytic agent, has been extensively researched and evaluated pre-clinically to support its use in humans for nutritional supplementation.
Media Contact Information
Portia Xu
portia.xu@expressrxgroup.com
SOURCE: Express Rx
View the original press release on accesswire.com
